Following the current path, stroke cases will increase by 28.9% between 2003 and 2023 (estimates do not include strokes among the institutionalized population). If an alternative path is taken, there will be 18.8% (589,000) fewer stroke cases.
Between 1988 & 1994 and 1999 & 2004, use of pharmacological lipid-lowering treatment increased from 11.7% to 40.8%. Low-density lipoprotein cholesterol control increased from 4.0% to 25.1% among those with
high… [ Get More Details ]
Pioglitazone associated with relative risk reduction in recurrent stroke
The PROactive trial to manage glucose in diabetics with a history of cardiovascular disease, stroke, or other vascular risk factors found that treatment with pioglitazone was associated with a 47% relative… [ Get More Details ]
According to the Pharmaceutical Research and Manufacturers of America, 13 medicines are currently in development for stroke.
[ Get More Details ]
The volume of mitral valve surgical procedures increased approximately 8.3% from 2010 to 2013.